GCA Consortium

What's involved: Clinical and immunogenetic characterization of Giant Cell Arteritis (GCA) and polymyalgia rheumatica (PMR)
Take part: Open
Principal Investigator: Mr Peter Lanyon

Research Theme | Musculoskeletal | Open Trials

What's involved

Clinical and immunogenetic characterization of Giant Cell Arteritis (GCA) and polymyalgia rheumatica (PMR)

Principal Investigator

Mr Peter Lanyon

Take part

Open

Back to all trials

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute

What's involved

Principal Investigator

Take part

Contact Us

Hosted by